Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical Oral Investigations
Published in: Clinical Oral Investigations 3/2017

01-04-2017 | Original Article

Does Botulinum neurotoxin type A treatment for sialorrhea change oral health?

Authors: Janne Tiigimäe-Saar, Pille Taba, Tiia Tamme

Published in: Clinical Oral Investigations | Issue 3/2017

Login to get access

Abstract

Objectives

Botulinum neurotoxin type A (BNT-A) intrasalivary gland injections in patients with neurological disorders have been known to effectively treat hypersalivation. However, oral health can be compromised with increasing the dose. The aim of this study was to find out the therapeutic effect of low-dose, ultrasonography-controlled BNT-A injections into the bilateral parotid and submandibular glands on oral health in the treatment of sialorrhea.

Material and methods

Twenty patients diagnosed with Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), and other neurological disorders, including stroke or birth trauma, received BNT-A injections with salivary tests before and 1 month after the injections. Drooling was evaluated using subjective scales and objective assessment of salivary flow rate and oral health (salivary composition and cariogenic bacterial counts).

Results

A significant decrease was found in salivary flow rate at 1- and 3-month follow-up in the BNT-A treated group. There was no significant change in salivary composition or cariogenic bacterial counts.

Conclusion

BNT-A injections according to the current protocol can effectively manage sialorrhea while maintaining oral health.

Clinical relevance

Oral health can be considered the mirror of general human health, as the cause of many diseases. Saliva plays a crucial role in protecting the oral cavity. The present study is of high clinical relevance because, although earlier research has proved the effect of Botulinum neurotoxin type A injections on reduction in saliva flow, data about the risks of the treatment method to the oral condition through affecting saliva composition has so far been missing.
Appendix
Available only for authorised users
Literature
1.
Daugherty KK (2007) Botulinum toxin A in the treatment of sialorrhea. Benson J 41:79–85
2.
Taba P, Asser T (2002) Prevalence of Parkinson’s disease in Estonia. Acta Neurol Scan 106(5):276–81CrossRef
3.
Mancini F, Zangaglia R, Sommaruga MG, Martignoni E, Nappi G, Pacchetti C (2003) Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism. Mov Disord 18:685–688CrossRefPubMed
4.
Katie P-HW, Ke J-Y, Chen C-Y, Chen C-L, Chou M-Y, Pei Y-C (2011) Botulinum toxin type a on oral health in treating sialorrhea in children with cerebral palsy: a randomized, double-blind, placebo-controlled study. J Child Neurol 26:838–843CrossRef
5.
Weikamp JG, Schinagl DA, Verstappen CC, Schelhaas HJ, de Swart BJ, Kalf JG (2016) Botulinum toxin-A injections vs radiotherapy for drooling in ALS. Acta Neurol Scand. doi:10.​1111/​ane.​12559 PubMed
6.
Heintze U, Birkhed D, Björn H (1983) Secretion rate and buffer effect of resting and stimulated whole saliva as a function of age and sex. Swed Dent J 7(6):227–38PubMed
7.
López-Jornet P, Bermejo-Fenoll A, Bagán-Sebastian JV, Pascula Gómez E (1996) Comparison of a new test for the measurement of resting whole saliva with the draining and the swab techniques. Braz Dent J 7:81–6PubMed
8.
Jongerius PH, van den Hoogen FJ, van Limbeek J et al (2004) The effect of botulinum toxin in the treatment of drooling: a controlled clinical trial. Pediatrics 114:620–627CrossRefPubMed
9.
Lagalla G, Millevolte M, Capecci M, Provinciali L, Ceravolo MG (2006) Botulinum toxin type A for drooling in Parkinson’s disease: a double-blind, randomized, placebo-controlled study. Mov Disord 21:704–707CrossRefPubMed
10.
Pienihäkkinen K, Jokela J (1995) A simple method for monitoring mutans streptococci in young children. Eur J Oral Sci 103:61–2CrossRefPubMed
11.
Goetz CG, Tilley BC, Shaftman SR et al (2008) Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23:2129–70CrossRefPubMed
12.
Christian A, Bardac DI (2013) Effects of occupational hazards on saliva. AMT 2(1):293–295
13.
Thorild I, Lindau-Jonson B, Twetman S (2002) Prevalence of Streptococcus mutans in mothers and in their preschool children. Int J Paediatr Dent 12:2–7PubMed
14.
Petersson H, Twetman S, Bratthall D (2002) Evaluation of a computer program for caries risk assessment in schoolchildren. Caries Res 36:327–40CrossRef
15.
Crossner C-G, Hagberg C (1977) A clinical and microbiological evaluation of the dentocult dip-slide test. Swed Dent J 1:85–94PubMed
16.
Birkhed D, Edwardsson S, Andersson H (1981) Comparison among a dip-slide test (Dentocult), plate count, and Snyder test for estimating number of lactobacilli in human saliva. J Dent Res 60:1832–40CrossRefPubMed
17.
Schlagenhauf U, Pommerencke K, Weiger R (1995) Influence of toothbrushing, eating and smoking on Dentocult® SM Strip mutans test scores. Oral Microbiol Immunol 10:98–101CrossRefPubMed
18.
Wilken B, Aslami B, Backes H (2008) Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B. Neuropediatrics 39:200–4CrossRefPubMed
19.
Sriskandan N, Moody A, Howlett DC (2010) Ultrasound-guided submandibular gland injection of botulinum toxin for hypersalivation in cerebral palsy. Br J Oral Maxillofac Surg 48:58–60CrossRefPubMed
20.
Suskind DL, Tilton A, Suskind DL, Tilton A (2002) Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy. Laryngoscope 112:73–81CrossRefPubMed
21.
Fuster Torres MA, Berini Aytes L, Gay Escoda C et al (2007) Salivary gland application of botulinum toxin for the treatment of sialorrhea. Med Oral Patol Oral Cir Bucal 12:E511–E517PubMed
22.
Gopinath VK, Arzreanne AR (2006) Saliva as a diagnostic tool for assessment of dental caries. Arch Orofac Sci 1:57–59
23.
24.
Sharma E, Vishwanathamurthy RA, Nadella M, Savitha AN, Gundannavar G, Hussain MA (2012) A randomised study to compare salivary pH, calcium, phosphate and calculus formation after using anticavity dentifrices containing Recaldent(®) and functionalized tri-calcium phosphate. J Indian Soc Periodontol 16:504–7CrossRefPubMedPubMedCentral
25.
Brambilla E, Twetman S, Felloni A et al (1999) Salivary mutans streptococci and lactobacilli in 9- and 13-year-old Italian schoolchildren and the relation to oral health. Clin Oral Investig 3:7–10CrossRefPubMed
26.
Crossner C-G, Claesson R, Johansson T (1989) Presence of mutans streptococci and various types of lactobacilli in interdental spaces related to development of proximal carious lesions. Scand J Dent Res 97:307–15PubMed
27.
Gabre P, Martinsson T, Gahnberg L (1999) Simplified sampling methods for estimating levels of lactobacilli in saliva in dental clinical practice. Acta Odontol Scand 57:181–4CrossRefPubMed
28.
Larmas M (1975) A new dip-slide method for the counting of salivary lactobacilli. Proc Finn Dent Soc 71:31–5PubMed
29.
Parvinen T (1984) Flow rate, pH, and Lactobacillus and yeast counts of stimulated whole saliva in adults [dissertation]. University of Turku, Turku, Finland
30.
Larmas M (1992) Saliva and dental caries: diagnostic tests for normal dental practice. Int Dent J 42:199–208PubMed
31.
Pradeep AR, Singh SP, Martande SS, Raju AP, Rustagi T, Suke DK, Naik SB (2013) Clinical evaluation of the periodontal health condition and oral health awareness in Parkinson’s disease patients. Gerodontology doi. doi:10.​1111/​ger.​12055
32.
Erbe C, Klukowska M, Tsaknaki I, Timm H, Grender J, Wehrbein H (2013) Efficacy of 3 toothbrush treatments on plaque removal in orthodontic patients assessed with digital plaque imaging: a randomized controlled trial. Am J Orthod Dentofacial Orthop 143:760–6CrossRefPubMed
33.
Prendergast V, Jakobsson U, Renvert S, Hallberg IR (2012) Effects of a standard versus comprehensive oral care protocol among intubated neuroscience ICU patients: results of a randomized controlled trial. J Neurosci Nurs 44:134–46CrossRefPubMed
34.
Rath SK, Singh M (2013) Comparative clinical and microbiological efficacy of mouthwashes containing 0.2% and 0.12% chlorhexidine. Dent Res J (Isfahan) 10:364–9
Metadata
Title
Does Botulinum neurotoxin type A treatment for sialorrhea change oral health?
Authors
Janne Tiigimäe-Saar
Pille Taba
Tiia Tamme
Publication date
01-04-2017
Publisher
Springer Berlin Heidelberg
Published in
Clinical Oral Investigations / Issue 3/2017
Print ISSN: 1432-6981
Electronic ISSN: 1436-3771
DOI
https://doi.org/10.1007/s00784-016-1826-z

Other articles of this Issue 3/2017

Clinical Oral Investigations 3/2017 Go to the issue

Original Article

Longevity and associated risk factors in adhesive restorations of young permanent teeth after complete and selective caries removal: a retrospective study

Original Article

Efficacy of calcium oxide and calcium hydroxide nanoparticles on the elimination of Enterococcus faecalis in human root dentin

Original Article

Long-term effect of periodontal surgery on oral health and metabolic control of diabetics

Original Article

Gingival crevicular fluid and serum hCAP18/LL-37 levels in generalized aggressive periodontitis

Original Article

The effect of various occlusal reduction levels on postoperative pain in teeth with symptomatic apical periodontitis using computerized analysis: a prospective, randomized, double-blind study

Review

Is there enough evidence to use botulinum toxin injections for bruxism management? A systematic literature review